Table 3.
(Poly)Phenol Metabolite 1 | Model | Dose and Time | Mechanistic Evidence | Ref. |
---|---|---|---|---|
Benzaldehydes | ||||
2—Hydroxy–4—Methoxybenzaldehyde | BZ555 Worms (dat1::gfp) | 2.5 mM Administered on Food for 24 h | ↓ Dopaminergic Neurodegeneration | [99] |
Benzoic Acids | ||||
3,4,5—Trihydroxybenzoic Acid (Gallic Acid) | Amyloid–Related Neurodegenerative Disease Model Expression of ATX3 in the Nervous System |
0.1 mM Administered to Food Scoring After 24 and 48 h |
↑ Mobility No Rescue in Lifespan |
[100] |
Cinnamic Acids | ||||
4—Hydroxy–3—Methoxycinnamic Acid (Ferulic Acid) | Alzheimer’s Model (Muscle–Specific Aβ—Expression) | 50 mM Administered on Food from Embryo | ↑ Survival Rate ↑ Protection against Aβ-Cytotoxicity |
[104] |
3,4—Dihydroxycinnamic Acid (Caffeic Acid) | Wt Mt(Mev-1), A Strain Hypersensitive To Oxidative Stress |
100 µM to 600 µM (Strongest Effect at 300 µM) |
↑ Lifespan WT and Mt(mev–1) ↓ Body Size Altered Lipid–Metabolism Tendency to Delay Reproductive Time = Number of Offspring ↓ Gene Expression of Hsp–3, Hsp–17, and Hsp–16.41 ↑ Gene Expression of Hsp–12.6 |
[102] |
Cinnamic Acid | Alzheimer’s Model Strain CL4176 Expressing Human Aβ | 40, 80, or 200 μM Throughout Development |
↓ Aβ40 Fibrillogenesis ↓ Aβ40–Induced Cytotoxicity Ameliorate AD–Like Symptoms of Worm Paralysis |
[101] |
2—Hydroxycinnamic Acid | ||||
3—Hydroxycinnamic Acid | ||||
2,4—Dihydroxycinnamic | ||||
3,4,5—Trihydroxycinnamic Acid |
WT—wild type; Aβ—Amyloid beta 42; ATX3—Ataxin 3; Hsp—heat shock protein; dat1—dopamine transporter 1. 1 (Poly)phenol metabolites are named accordingly the recommendations recently published [32], however the name cited in the original publications where the effect is described is indicated in brackets. ↑—increased ↓—decreased.